Medicare seeks to negotiate prices on 15 drugs, including Novo Nordisk's (NVO) GLP-1 weight-loss drugs Ozempic and Wegovy, in ...

U.S. stock index futures jumped on Friday, with Wall Street looking to deliver its best week since the election in November ...

According to Evaluate Pharma, China's growing influence in pharmaceutical R&D is a key theme to watch in 2025. The pharma ...

ClearBridge Investments, an investment management company, released its “ClearBridge Large Cap Growth Strategy” fourth ...

Since being added to the Focus List on March 7, 2023 at $72.38 per share, shares of NVO have increased 42.91% to $103.44. The stock is currently a #3 (Hold) on the Zacks Rank. For fiscal 2024 ...

Kuykendall has been in his current role since July 2022. Interesting fact: He has worked with Novo Nordisk for more than 18 ...

Weight-loss drugs have dominated the pharmaceutical market with their rapid success. Barclays head of European pharmaceuticals research, Emily Field, joins Seana Smith and Brad Smith on Morning Brief ...

NVO’s trailing and forward P/E were 28.92 and ... Dive into the AI gold rush and watch your portfolio soar alongside the brightest minds of our generation. This isn’t just about making money ...

Shares of NVO declined on the news ... MRK & ABBV’s M&A Deals) Watch this space for regular pipeline and regulatory updates next week. Pfizer has a Zacks Rank #2 (Buy), while Lilly, Sanofi ...

Pharmaceutical giant Eli Lilly & Co. (LLY) is buying privately held Scorpion Therapeutics’ experimental cancer therapy for $2 ...

Investors are appraising Trump policies' likely impact on stocks on the last trading day before the inauguration.

I chose a mix of companies in different industries that could provide significant upside for long-term investors. Watch the short video to learn more, consider subscribing, and click the special offer ...